Global Primary Biliary Cholangitis Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 76 pages | ID: G0EC702813DEN
LP Information

Abstracts

According to this study, the global Primary Biliary Cholangitis Therapeutics market size will reach US$ million by 2031.

Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Primary Biliary Cholangitis Therapeutics Industry Forecast” looks at past sales and reviews total world Primary Biliary Cholangitis Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Primary Biliary Cholangitis Therapeutics sales for 2025 through 2031. With Primary Biliary Cholangitis Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Primary Biliary Cholangitis Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Primary Biliary Cholangitis Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Primary Biliary Cholangitis Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Primary Biliary Cholangitis Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Primary Biliary Cholangitis Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Primary Biliary Cholangitis Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Primary Biliary Cholangitis Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• OCALIVA
• Ursodiol
• Others

Segmentation by Application:

• Hospital
• Private Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott Laboratories
• Allergan Plc
• Eli Lilly and Co.
• Intercept Pharmaceuticals Inc.
• Takeda Pharmaceutical Co. Ltd.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Primary Biliary Cholangitis Therapeutics Market Size (2020-2031)
  2.1.2 Primary Biliary Cholangitis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Primary Biliary Cholangitis Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Primary Biliary Cholangitis Therapeutics Segment by Type
  2.2.1 OCALIVA
  2.2.2 Ursodiol
  2.2.3 Others
2.3 Primary Biliary Cholangitis Therapeutics Market Size by Type
  2.3.1 Primary Biliary Cholangitis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Primary Biliary Cholangitis Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Primary Biliary Cholangitis Therapeutics Segment by Application
  2.4.1 Hospital
  2.4.2 Private Clinic
  2.4.3 Other
2.5 Primary Biliary Cholangitis Therapeutics Market Size by Application
  2.5.1 Primary Biliary Cholangitis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Primary Biliary Cholangitis Therapeutics Market Size Market Share by Application (2020-2025)

3 PRIMARY BILIARY CHOLANGITIS THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Primary Biliary Cholangitis Therapeutics Market Size Market Share by Player
  3.1.1 Global Primary Biliary Cholangitis Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Primary Biliary Cholangitis Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Primary Biliary Cholangitis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PRIMARY BILIARY CHOLANGITIS THERAPEUTICS BY REGION

4.1 Primary Biliary Cholangitis Therapeutics Market Size by Region (2020-2025)
4.2 Global Primary Biliary Cholangitis Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Primary Biliary Cholangitis Therapeutics Market Size Growth (2020-2025)
4.4 APAC Primary Biliary Cholangitis Therapeutics Market Size Growth (2020-2025)
4.5 Europe Primary Biliary Cholangitis Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Primary Biliary Cholangitis Therapeutics Market Size by Country (2020-2025)
5.2 Americas Primary Biliary Cholangitis Therapeutics Market Size by Type (2020-2025)
5.3 Americas Primary Biliary Cholangitis Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Primary Biliary Cholangitis Therapeutics Market Size by Region (2020-2025)
6.2 APAC Primary Biliary Cholangitis Therapeutics Market Size by Type (2020-2025)
6.3 APAC Primary Biliary Cholangitis Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Primary Biliary Cholangitis Therapeutics Market Size by Country (2020-2025)
7.2 Europe Primary Biliary Cholangitis Therapeutics Market Size by Type (2020-2025)
7.3 Europe Primary Biliary Cholangitis Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Primary Biliary Cholangitis Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PRIMARY BILIARY CHOLANGITIS THERAPEUTICS MARKET FORECAST

10.1 Global Primary Biliary Cholangitis Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Primary Biliary Cholangitis Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Primary Biliary Cholangitis Therapeutics Forecast
  10.1.3 APAC Primary Biliary Cholangitis Therapeutics Forecast
  10.1.4 Europe Primary Biliary Cholangitis Therapeutics Forecast
  10.1.5 Middle East & Africa Primary Biliary Cholangitis Therapeutics Forecast
10.2 Americas Primary Biliary Cholangitis Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Primary Biliary Cholangitis Therapeutics Forecast
  10.2.2 Canada Market Primary Biliary Cholangitis Therapeutics Forecast
  10.2.3 Mexico Market Primary Biliary Cholangitis Therapeutics Forecast
  10.2.4 Brazil Market Primary Biliary Cholangitis Therapeutics Forecast
10.3 APAC Primary Biliary Cholangitis Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Primary Biliary Cholangitis Therapeutics Market Forecast
  10.3.2 Japan Market Primary Biliary Cholangitis Therapeutics Forecast
  10.3.3 Korea Market Primary Biliary Cholangitis Therapeutics Forecast
  10.3.4 Southeast Asia Market Primary Biliary Cholangitis Therapeutics Forecast
  10.3.5 India Market Primary Biliary Cholangitis Therapeutics Forecast
  10.3.6 Australia Market Primary Biliary Cholangitis Therapeutics Forecast
10.4 Europe Primary Biliary Cholangitis Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Primary Biliary Cholangitis Therapeutics Forecast
  10.4.2 France Market Primary Biliary Cholangitis Therapeutics Forecast
  10.4.3 UK Market Primary Biliary Cholangitis Therapeutics Forecast
  10.4.4 Italy Market Primary Biliary Cholangitis Therapeutics Forecast
  10.4.5 Russia Market Primary Biliary Cholangitis Therapeutics Forecast
10.5 Middle East & Africa Primary Biliary Cholangitis Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Primary Biliary Cholangitis Therapeutics Forecast
  10.5.2 South Africa Market Primary Biliary Cholangitis Therapeutics Forecast
  10.5.3 Israel Market Primary Biliary Cholangitis Therapeutics Forecast
  10.5.4 Turkey Market Primary Biliary Cholangitis Therapeutics Forecast
10.6 Global Primary Biliary Cholangitis Therapeutics Forecast by Type (2026-2031)
10.7 Global Primary Biliary Cholangitis Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Primary Biliary Cholangitis Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Information
  11.1.2 Abbott Laboratories Primary Biliary Cholangitis Therapeutics Product Offered
  11.1.3 Abbott Laboratories Primary Biliary Cholangitis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Laboratories Main Business Overview
  11.1.5 Abbott Laboratories Latest Developments
11.2 Allergan Plc
  11.2.1 Allergan Plc Company Information
  11.2.2 Allergan Plc Primary Biliary Cholangitis Therapeutics Product Offered
  11.2.3 Allergan Plc Primary Biliary Cholangitis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Allergan Plc Main Business Overview
  11.2.5 Allergan Plc Latest Developments
11.3 Eli Lilly and Co.
  11.3.1 Eli Lilly and Co. Company Information
  11.3.2 Eli Lilly and Co. Primary Biliary Cholangitis Therapeutics Product Offered
  11.3.3 Eli Lilly and Co. Primary Biliary Cholangitis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Eli Lilly and Co. Main Business Overview
  11.3.5 Eli Lilly and Co. Latest Developments
11.4 Intercept Pharmaceuticals Inc.
  11.4.1 Intercept Pharmaceuticals Inc. Company Information
  11.4.2 Intercept Pharmaceuticals Inc. Primary Biliary Cholangitis Therapeutics Product Offered
  11.4.3 Intercept Pharmaceuticals Inc. Primary Biliary Cholangitis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Intercept Pharmaceuticals Inc. Main Business Overview
  11.4.5 Intercept Pharmaceuticals Inc. Latest Developments
11.5 Takeda Pharmaceutical Co. Ltd.
  11.5.1 Takeda Pharmaceutical Co. Ltd. Company Information
  11.5.2 Takeda Pharmaceutical Co. Ltd. Primary Biliary Cholangitis Therapeutics Product Offered
  11.5.3 Takeda Pharmaceutical Co. Ltd. Primary Biliary Cholangitis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Takeda Pharmaceutical Co. Ltd. Main Business Overview
  11.5.5 Takeda Pharmaceutical Co. Ltd. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Primary Biliary Cholangitis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Primary Biliary Cholangitis Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of OCALIVA
Table 4. Major Players of Ursodiol
Table 5. Major Players of Others
Table 6. Primary Biliary Cholangitis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Primary Biliary Cholangitis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Primary Biliary Cholangitis Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Primary Biliary Cholangitis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Primary Biliary Cholangitis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Primary Biliary Cholangitis Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Primary Biliary Cholangitis Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Primary Biliary Cholangitis Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Primary Biliary Cholangitis Therapeutics Key Players Head office and Products Offered
Table 15. Primary Biliary Cholangitis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Primary Biliary Cholangitis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Primary Biliary Cholangitis Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Primary Biliary Cholangitis Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Primary Biliary Cholangitis Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Primary Biliary Cholangitis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Primary Biliary Cholangitis Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Primary Biliary Cholangitis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Primary Biliary Cholangitis Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Primary Biliary Cholangitis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Primary Biliary Cholangitis Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Primary Biliary Cholangitis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Primary Biliary Cholangitis Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Primary Biliary Cholangitis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Primary Biliary Cholangitis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Primary Biliary Cholangitis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Primary Biliary Cholangitis Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Primary Biliary Cholangitis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Primary Biliary Cholangitis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Primary Biliary Cholangitis Therapeutics
Table 40. Key Market Challenges & Risks of Primary Biliary Cholangitis Therapeutics
Table 41. Key Industry Trends of Primary Biliary Cholangitis Therapeutics
Table 42. Global Primary Biliary Cholangitis Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Primary Biliary Cholangitis Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Primary Biliary Cholangitis Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Primary Biliary Cholangitis Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Abbott Laboratories Details, Company Type, Primary Biliary Cholangitis Therapeutics Area Served and Its Competitors
Table 47. Abbott Laboratories Primary Biliary Cholangitis Therapeutics Product Offered
Table 48. Abbott Laboratories Primary Biliary Cholangitis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Abbott Laboratories Main Business
Table 50. Abbott Laboratories Latest Developments
Table 51. Allergan Plc Details, Company Type, Primary Biliary Cholangitis Therapeutics Area Served and Its Competitors
Table 52. Allergan Plc Primary Biliary Cholangitis Therapeutics Product Offered
Table 53. Allergan Plc Primary Biliary Cholangitis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Allergan Plc Main Business
Table 55. Allergan Plc Latest Developments
Table 56. Eli Lilly and Co. Details, Company Type, Primary Biliary Cholangitis Therapeutics Area Served and Its Competitors
Table 57. Eli Lilly and Co. Primary Biliary Cholangitis Therapeutics Product Offered
Table 58. Eli Lilly and Co. Primary Biliary Cholangitis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Eli Lilly and Co. Main Business
Table 60. Eli Lilly and Co. Latest Developments
Table 61. Intercept Pharmaceuticals Inc. Details, Company Type, Primary Biliary Cholangitis Therapeutics Area Served and Its Competitors
Table 62. Intercept Pharmaceuticals Inc. Primary Biliary Cholangitis Therapeutics Product Offered
Table 63. Intercept Pharmaceuticals Inc. Primary Biliary Cholangitis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Intercept Pharmaceuticals Inc. Main Business
Table 65. Intercept Pharmaceuticals Inc. Latest Developments
Table 66. Takeda Pharmaceutical Co. Ltd. Details, Company Type, Primary Biliary Cholangitis Therapeutics Area Served and Its Competitors
Table 67. Takeda Pharmaceutical Co. Ltd. Primary Biliary Cholangitis Therapeutics Product Offered
Table 68. Takeda Pharmaceutical Co. Ltd. Primary Biliary Cholangitis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Takeda Pharmaceutical Co. Ltd. Main Business
Table 70. Takeda Pharmaceutical Co. Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Primary Biliary Cholangitis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Primary Biliary Cholangitis Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Primary Biliary Cholangitis Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Primary Biliary Cholangitis Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Primary Biliary Cholangitis Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Primary Biliary Cholangitis Therapeutics Market Size Market Share by Type in 2024
Figure 10. Primary Biliary Cholangitis Therapeutics in Hospital
Figure 11. Global Primary Biliary Cholangitis Therapeutics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Primary Biliary Cholangitis Therapeutics in Private Clinic
Figure 13. Global Primary Biliary Cholangitis Therapeutics Market: Private Clinic (2020-2025) & ($ millions)
Figure 14. Primary Biliary Cholangitis Therapeutics in Other
Figure 15. Global Primary Biliary Cholangitis Therapeutics Market: Other (2020-2025) & ($ millions)
Figure 16. Global Primary Biliary Cholangitis Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Primary Biliary Cholangitis Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Primary Biliary Cholangitis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Primary Biliary Cholangitis Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Primary Biliary Cholangitis Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Primary Biliary Cholangitis Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Primary Biliary Cholangitis Therapeutics Value Market Share by Country in 2024
Figure 24. United States Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Primary Biliary Cholangitis Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Primary Biliary Cholangitis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Primary Biliary Cholangitis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Primary Biliary Cholangitis Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Primary Biliary Cholangitis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Primary Biliary Cholangitis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Primary Biliary Cholangitis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Primary Biliary Cholangitis Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Primary Biliary Cholangitis Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Primary Biliary Cholangitis Therapeutics Market Size 2026-2031 ($ millions)